APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Codeine Drug Market Analysis and Forecast 2026-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchCodeine Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Drug Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Codeine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Codeine Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Codeine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Codeine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Codeine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Codeine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Codeine Drug include Apotex, Aristo Pharma GmbH, Cipla, Hikma, Laboratoire Riva, Lannett Company, Mallinckrodt, Medreich and Pharmaceutical Associates, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Codeine Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Codeine Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Codeine Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Codeine Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Codeine Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Codeine Drug revenue, projected growth trends, production technology, application and end-user industry.

Codeine Drug Segment by Company

Apotex

Aristo Pharma GmbH

Cipla

Hikma

Laboratoire Riva

Lannett Company

Mallinckrodt

Medreich

Pharmaceutical Associates

Sanofi Aventis

Taiji

Viatris

Novartis

Johnson & Johnson

TEVA

Codeine Drug Segment by Type

Single-ingredient Codeine

Multi-ingredient Medications Codeine

Codeine Drug Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Codeine Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Codeine Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Codeine Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Codeine Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single-ingredient Codeine Major Player Table 3. Multi-ingredient Medications Codeine Major Player Table 4. Global Codeine Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Narcotic Analgesic Major Player Table 6. Antitussive Major Player Table 7. Others Major Player Table 8. Codeine Drug Industry Trends Table 9. Codeine Drug Industry Drivers Table 10. Codeine Drug Industry Opportunities and Challenges Table 11. Codeine Drug Industry Restraints Table 12. Global Codeine Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Codeine Drug Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Codeine Drug Market Share by Region (2021-2026) Table 15. Global Codeine Drug Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Codeine Drug Market Share by Region (2027-2032) Table 17. Global Codeine Drug Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Codeine Drug Revenue Market Share by Players (2021-2026) Table 19. Global Codeine Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Codeine Drug Key Players Headquarters & Area Served Table 21. Global Codeine Drug Players, Product Type & Application Table 22. Global Codeine Drug Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Codeine Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Codeine Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Codeine Drug Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Codeine Drug Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Codeine Drug Revenue Market Share by Type (2021-2026) Table 29. Global Codeine Drug Revenue Market Share by Type (2027-2032) Table 30. Global Codeine Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Codeine Drug Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Codeine Drug Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Codeine Drug Revenue Market Share by Application (2021-2026) Table 34. Global Codeine Drug Revenue Market Share by Application (2027-2032) Table 35. Apotex Company Information Table 36. Apotex Business Overview Table 37. Apotex Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Apotex Codeine Drug Product Portfolio Table 39. Apotex Recent Development Table 40. Aristo Pharma GmbH Company Information Table 41. Aristo Pharma GmbH Business Overview Table 42. Aristo Pharma GmbH Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Aristo Pharma GmbH Codeine Drug Product Portfolio Table 44. Aristo Pharma GmbH Recent Development Table 45. Cipla Company Information Table 46. Cipla Business Overview Table 47. Cipla Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Cipla Codeine Drug Product Portfolio Table 49. Cipla Recent Development Table 50. Hikma Company Information Table 51. Hikma Business Overview Table 52. Hikma Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Hikma Codeine Drug Product Portfolio Table 54. Hikma Recent Development Table 55. Laboratoire Riva Company Information Table 56. Laboratoire Riva Business Overview Table 57. Laboratoire Riva Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Laboratoire Riva Codeine Drug Product Portfolio Table 59. Laboratoire Riva Recent Development Table 60. Lannett Company Company Information Table 61. Lannett Company Business Overview Table 62. Lannett Company Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Lannett Company Codeine Drug Product Portfolio Table 64. Lannett Company Recent Development Table 65. Mallinckrodt Company Information Table 66. Mallinckrodt Business Overview Table 67. Mallinckrodt Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Mallinckrodt Codeine Drug Product Portfolio Table 69. Mallinckrodt Recent Development Table 70. Medreich Company Information Table 71. Medreich Business Overview Table 72. Medreich Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Medreich Codeine Drug Product Portfolio Table 74. Medreich Recent Development Table 75. Pharmaceutical Associates Company Information Table 76. Pharmaceutical Associates Business Overview Table 77. Pharmaceutical Associates Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Pharmaceutical Associates Codeine Drug Product Portfolio Table 79. Pharmaceutical Associates Recent Development Table 80. Sanofi Aventis Company Information Table 81. Sanofi Aventis Business Overview Table 82. Sanofi Aventis Codeine Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Sanofi Aventis Codeine Drug Product Portfolio Table 84. Sanofi Aventis Recent Development Table 85. Taiji Company Information Table 86. Taiji Business Overview Table 87. Taiji Codeine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Taiji Codeine Drug Product Portfolio Table 89. Taiji Recent Development Table 90. Viatris Company Information Table 91. Viatris Business Overview Table 92. Viatris Codeine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Viatris Codeine Drug Product Portfolio Table 94. Viatris Recent Development Table 95. Novartis Company Information Table 96. Novartis Business Overview Table 97. Novartis Codeine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Novartis Codeine Drug Product Portfolio Table 99. Novartis Recent Development Table 100. Johnson & Johnson Company Information Table 101. Johnson & Johnson Business Overview Table 102. Johnson & Johnson Codeine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Johnson & Johnson Codeine Drug Product Portfolio Table 104. Johnson & Johnson Recent Development Table 105. TEVA Company Information Table 106. TEVA Business Overview Table 107. TEVA Codeine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. TEVA Codeine Drug Product Portfolio Table 109. TEVA Recent Development Table 110. North America Codeine Drug Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Codeine Drug Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Codeine Drug Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Codeine Drug Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Codeine Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Codeine Drug Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Codeine Drug Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Codeine Drug Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Codeine Drug Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Codeine Drug Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Codeine Drug Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Codeine Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Codeine Drug Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Codeine Drug Revenue by Country (US$ Million) & (2027-2032) Table 124. China Codeine Drug Revenue by Type (2021-2026) & (US$ Million) Table 125. China Codeine Drug Revenue by Type (2027-2032) & (US$ Million) Table 126. China Codeine Drug Revenue by Application (2021-2026) & (US$ Million) Table 127. China Codeine Drug Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Codeine Drug Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Codeine Drug Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Codeine Drug Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Codeine Drug Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Codeine Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Codeine Drug Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Codeine Drug Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Codeine Drug Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Codeine Drug Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Codeine Drug Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Codeine Drug Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Codeine Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Codeine Drug Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Codeine Drug Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Codeine Drug Image Figure 2. Global Codeine Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single-ingredient Codeine Image Figure 5. Multi-ingredient Medications Codeine Image Figure 6. Global Codeine Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Codeine Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Narcotic Analgesic Image Figure 9. Antitussive Image Figure 10. Others Image Figure 11. Global Codeine Drug Market Size (US$ Million) & (2021-2032) Figure 12. Global Codeine Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Codeine Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Codeine Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Codeine Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Codeine Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Codeine Drug Revenue Market Share by Type (2021-2032) Figure 19. Global Codeine Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Codeine Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Codeine Drug Revenue Market Share by Application (2021-2032) Figure 22. North America Codeine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Codeine Drug Revenue Share by Type (2021-2032) Figure 24. North America Codeine Drug Revenue Share by Application (2021-2032) Figure 25. North America Codeine Drug Revenue Share by Country (2021-2032) Figure 26. United States Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Codeine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Codeine Drug Revenue Share by Type (2021-2032) Figure 31. Europe Codeine Drug Revenue Share by Application (2021-2032) Figure 32. Europe Codeine Drug Revenue Share by Country (2021-2032) Figure 33. Germany Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Codeine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Codeine Drug Revenue Share by Type (2021-2032) Figure 43. China Codeine Drug Revenue Share by Application (2021-2032) Figure 44. Asia Codeine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Codeine Drug Revenue Share by Type (2021-2032) Figure 46. Asia Codeine Drug Revenue Share by Application (2021-2032) Figure 47. Asia Codeine Drug Revenue Share by Region (2021-2032) Figure 48. Japan Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Codeine Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Codeine Drug Revenue Share by Type (2021-2032) Figure 56. SAMEA Codeine Drug Revenue Share by Application (2021-2032) Figure 57. SAMEA Codeine Drug Revenue Share by Country (2021-2032) Figure 58. Brazil Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Codeine Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications Codeine
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • Apotex
  • Aristo Pharma GmbH
  • Cipla
  • Hikma
  • Laboratoire Riva
  • Lannett Company
  • Mallinckrodt
  • Medreich
  • Pharmaceutical Associates
  • Sanofi Aventis
  • Taiji
  • Viatris
  • Novartis
  • Johnson & Johnson
  • TEVA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Codeine Drug Market by Type
  3. 1.2.1 Global Codeine Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single-ingredient Codeine
  5. 1.2.3 Multi-ingredient Medications Codeine
  6. 1.3 Codeine Drug Market by Application
  7. 1.3.1 Global Codeine Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Narcotic Analgesic
  9. 1.3.3 Antitussive
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Codeine Drug Market Dynamics
  1. 2.1 Codeine Drug Industry Trends
  2. 2.2 Codeine Drug Industry Drivers
  3. 2.3 Codeine Drug Industry Opportunities and Challenges
  4. 2.4 Codeine Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Codeine Drug Market Perspective (2021-2032)
  2. 3.2 Global Codeine Drug Growth Trends by Region
  3. 3.2.1 Global Codeine Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Codeine Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Codeine Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Codeine Drug Revenue by Players
  2. 4.1.1 Global Codeine Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Codeine Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Codeine Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Codeine Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Codeine Drug Key Players Headquarters & Area Served
  7. 4.4 Global Codeine Drug Players, Product Type & Application
  8. 4.5 Global Codeine Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Codeine Drug Market CR5 and HHI
  11. 4.6.3 2025 Codeine Drug Tier 1, Tier 2, and Tier 3
5 Codeine Drug Market Size by Type
  1. 5.1 Global Codeine Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Codeine Drug Revenue by Type (2021-2032)
  3. 5.3 Global Codeine Drug Revenue Market Share by Type (2021-2032)
6 Codeine Drug Market Size by Application
  1. 6.1 Global Codeine Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Codeine Drug Revenue by Application (2021-2032)
  3. 6.3 Global Codeine Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Apotex
  2. 7.1.1 Apotex Company Information
  3. 7.1.2 Apotex Business Overview
  4. 7.1.3 Apotex Codeine Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Apotex Codeine Drug Product Portfolio
  6. 7.1.5 Apotex Recent Developments
  7. 7.2 Aristo Pharma GmbH
  8. 7.2.1 Aristo Pharma GmbH Company Information
  9. 7.2.2 Aristo Pharma GmbH Business Overview
  10. 7.2.3 Aristo Pharma GmbH Codeine Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Aristo Pharma GmbH Codeine Drug Product Portfolio
  12. 7.2.5 Aristo Pharma GmbH Recent Developments
  13. 7.3 Cipla
  14. 7.3.1 Cipla Company Information
  15. 7.3.2 Cipla Business Overview
  16. 7.3.3 Cipla Codeine Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cipla Codeine Drug Product Portfolio
  18. 7.3.5 Cipla Recent Developments
  19. 7.4 Hikma
  20. 7.4.1 Hikma Company Information
  21. 7.4.2 Hikma Business Overview
  22. 7.4.3 Hikma Codeine Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Hikma Codeine Drug Product Portfolio
  24. 7.4.5 Hikma Recent Developments
  25. 7.5 Laboratoire Riva
  26. 7.5.1 Laboratoire Riva Company Information
  27. 7.5.2 Laboratoire Riva Business Overview
  28. 7.5.3 Laboratoire Riva Codeine Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Laboratoire Riva Codeine Drug Product Portfolio
  30. 7.5.5 Laboratoire Riva Recent Developments
  31. 7.6 Lannett Company
  32. 7.6.1 Lannett Company Company Information
  33. 7.6.2 Lannett Company Business Overview
  34. 7.6.3 Lannett Company Codeine Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Lannett Company Codeine Drug Product Portfolio
  36. 7.6.5 Lannett Company Recent Developments
  37. 7.7 Mallinckrodt
  38. 7.7.1 Mallinckrodt Company Information
  39. 7.7.2 Mallinckrodt Business Overview
  40. 7.7.3 Mallinckrodt Codeine Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Mallinckrodt Codeine Drug Product Portfolio
  42. 7.7.5 Mallinckrodt Recent Developments
  43. 7.8 Medreich
  44. 7.8.1 Medreich Company Information
  45. 7.8.2 Medreich Business Overview
  46. 7.8.3 Medreich Codeine Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Medreich Codeine Drug Product Portfolio
  48. 7.8.5 Medreich Recent Developments
  49. 7.9 Pharmaceutical Associates
  50. 7.9.1 Pharmaceutical Associates Company Information
  51. 7.9.2 Pharmaceutical Associates Business Overview
  52. 7.9.3 Pharmaceutical Associates Codeine Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pharmaceutical Associates Codeine Drug Product Portfolio
  54. 7.9.5 Pharmaceutical Associates Recent Developments
  55. 7.10 Sanofi Aventis
  56. 7.10.1 Sanofi Aventis Company Information
  57. 7.10.2 Sanofi Aventis Business Overview
  58. 7.10.3 Sanofi Aventis Codeine Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sanofi Aventis Codeine Drug Product Portfolio
  60. 7.10.5 Sanofi Aventis Recent Developments
  61. 7.11 Taiji
  62. 7.11.1 Taiji Company Information
  63. 7.11.2 Taiji Business Overview
  64. 7.11.3 Taiji Codeine Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Taiji Codeine Drug Product Portfolio
  66. 7.11.5 Taiji Recent Developments
  67. 7.12 Viatris
  68. 7.12.1 Viatris Company Information
  69. 7.12.2 Viatris Business Overview
  70. 7.12.3 Viatris Codeine Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Viatris Codeine Drug Product Portfolio
  72. 7.12.5 Viatris Recent Developments
  73. 7.13 Novartis
  74. 7.13.1 Novartis Company Information
  75. 7.13.2 Novartis Business Overview
  76. 7.13.3 Novartis Codeine Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Novartis Codeine Drug Product Portfolio
  78. 7.13.5 Novartis Recent Developments
  79. 7.14 Johnson & Johnson
  80. 7.14.1 Johnson & Johnson Company Information
  81. 7.14.2 Johnson & Johnson Business Overview
  82. 7.14.3 Johnson & Johnson Codeine Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Johnson & Johnson Codeine Drug Product Portfolio
  84. 7.14.5 Johnson & Johnson Recent Developments
  85. 7.15 TEVA
  86. 7.15.1 TEVA Company Information
  87. 7.15.2 TEVA Business Overview
  88. 7.15.3 TEVA Codeine Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 TEVA Codeine Drug Product Portfolio
  90. 7.15.5 TEVA Recent Developments
8 North America
  1. 8.1 North America Codeine Drug Revenue (2021-2032)
  2. 8.2 North America Codeine Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Codeine Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Codeine Drug Revenue by Type (2027-2032)
  5. 8.3 North America Codeine Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Codeine Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Codeine Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Codeine Drug Revenue by Application (2027-2032)
  9. 8.5 North America Codeine Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Codeine Drug Revenue by Country
  11. 8.6.1 North America Codeine Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Codeine Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Codeine Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Codeine Drug Revenue (2021-2032)
  2. 9.2 Europe Codeine Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Codeine Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Codeine Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Codeine Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Codeine Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Codeine Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Codeine Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Codeine Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Codeine Drug Revenue by Country
  11. 9.6.1 Europe Codeine Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Codeine Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Codeine Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Codeine Drug Revenue (2021-2032)
  2. 10.2 China Codeine Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Codeine Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Codeine Drug Revenue by Type (2027-2032)
  5. 10.3 China Codeine Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Codeine Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Codeine Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Codeine Drug Revenue by Application (2027-2032)
  9. 10.5 China Codeine Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Codeine Drug Revenue (2021-2032)
  2. 11.2 Asia Codeine Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Codeine Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Codeine Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Codeine Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Codeine Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Codeine Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Codeine Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Codeine Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Codeine Drug Revenue by Country
  11. 11.6.1 Asia Codeine Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Codeine Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Codeine Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Codeine Drug Revenue (2021-2032)
  2. 12.2 SAMEA Codeine Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Codeine Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Codeine Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Codeine Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Codeine Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Codeine Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Codeine Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Codeine Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Codeine Drug Revenue by Country
  11. 12.6.1 SAMEA Codeine Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Codeine Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Codeine Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst